| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Makena Clinical Criteria for Authorization via Medical Benefit (TX.PHAR.15) - RETIRED (Medicaid April 10, 2022) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Netarsudil (Rhopressa), Netarsudil/Latanoprost (Rocklatan) (CP.PMN.118)- RETIRED (Ambetter March 1, 2023) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Nebivolol (Bystolic) (HIM.PA.131) - RETIRED (Ambetter June 1, 2022) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Natalizumab (Tysabri) (HIM.PA.SP17) - RETIRED (Ambetter June 1, 2022) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Lorcaserin (Belviq, Belviq XR) (CP.PCH.03) - RETIRED (Ambetter June 1, 2022) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Cerliponase alfa (Brineura) (TX.PHAR.46) - RETIRED (Medicaid January 24, 2022) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Pegademase Bovine (Adagen) (CP.PHAR.392) - RETIRED (Medicaid and Ambetter December 1, 2021 | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Human Growth Hormone (Somapacitan, Somatropin) (CP.PCH.39) - RETIRED (Ambetter December 1, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Bremelanotide (Vyleesi) (CP.PHAR.434) - RETIRED (Ambetter December 1, 2021) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Handling Authorizations for Transportation (TX.UM.10.07) - RETIRED (Medicaid November 1, 2021 | |